Synthesis and in vitro inhibition properties of siRNA conjugates carrying glucose and galactose with different presentations

Mol Divers. 2011 Aug;15(3):751-7. doi: 10.1007/s11030-011-9305-6. Epub 2011 Jan 26.

Abstract

Oligoribonucleotide conjugates and the corresponding siRNA duplexes against tumor necrosis factor carrying one, two, or four glucose and galactose residues at the 5'-end have been prepared using phosphoramidite chemistry. Carbohydrate-modified siRNA duplexes have similar inhibitory properties than unmodified RNA duplexes in HeLa cells transfected with oligofectamine. When HeLa cells were treated with siRNA carrying one, two, or four glucose residues without oligofectamine, no inhibition was observed. The inhibitory properties of siRNA carrying galactose residues without transfecting agent were tested on HuH-7 cells that have abundant asialoglycoprotein receptors. In these cells siRNA carrying galactose residues have slight anti-TNF inhibitory properties (25% in the best case) that are eliminated if the receptors are blocked with a competitor. These results demonstrate receptor-mediated uptake of siRNA carrying galactose residues, although the efficacy of the process is not enough for efficient RNA interference experiments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Drug Design*
  • Galactose / chemistry
  • Glucose / chemistry
  • HeLa Cells
  • Humans
  • Lipids / pharmacology
  • Organophosphorus Compounds / chemistry
  • RNA Interference
  • RNA, Small Interfering* / chemical synthesis
  • RNA, Small Interfering* / chemistry
  • RNA, Small Interfering* / genetics
  • RNA, Small Interfering* / metabolism
  • Tumor Necrosis Factors / chemistry
  • Tumor Necrosis Factors / genetics*

Substances

  • Lipids
  • Organophosphorus Compounds
  • RNA, Small Interfering
  • Tumor Necrosis Factors
  • oligofectamine
  • phosphoramidite
  • Glucose
  • Galactose